121 related articles for article (PubMed ID: 12532627)
1. [The combination on conjugated estrogens and medroxyprogesterone in the post-menopause patient and risk of breast cancer: analysis of an uncertain statistic].
Palma-Aguirre JA; del-Razo OE
Gac Med Mex; 2002; 138(6):591-2. PubMed ID: 12532627
[No Abstract] [Full Text] [Related]
2. Re: Estrogen plus progestin therapy and breast cancer in recently postmenopausal women.
Langer RD
Am J Epidemiol; 2009 Mar; 169(6):784-5; author reply 785-6. PubMed ID: 19208722
[No Abstract] [Full Text] [Related]
3. Women seek alternatives to hormone replacement therapy.
Altern Ther Health Med; 2002; 8(5):27. PubMed ID: 12233798
[No Abstract] [Full Text] [Related]
4. Be careful of what you wish for: putting the WHI Estrogen/Progestin and HERS II Trials in perspective.
Randolph JF;
Medscape Womens Health; 2002; 7(4):7. PubMed ID: 12466739
[No Abstract] [Full Text] [Related]
5. Combination hormone replacement therapy and dementia.
Wooltorton E
CMAJ; 2003 Jul; 169(2):133. PubMed ID: 12874164
[No Abstract] [Full Text] [Related]
6. The Women's Health Initiative estrogen plus progestin trial: the study and how it changes our practice.
Hendrix SL
J Am Osteopath Assoc; 2003 Feb; 103(2 Suppl 2):S3-5. PubMed ID: 12625631
[No Abstract] [Full Text] [Related]
7. Post-treatment change in serum estrone predicts mammographic percent density changes in women who received combination estrogen and progestin in the Postmenopausal Estrogen/Progestin Interventions (PEPI) Trial.
Ursin G; Palla SL; Reboussin BA; Slone S; Wasilauskas C; Pike MC; Greendale GA
J Clin Oncol; 2004 Jul; 22(14):2842-8. PubMed ID: 15254051
[TBL] [Abstract][Full Text] [Related]
8. Hormone replacement therapy and risk of heart disease.
Elliott KK
Am Fam Physician; 1999 Nov; 60(8):2234, 2237. PubMed ID: 10593314
[No Abstract] [Full Text] [Related]
9. A clinician's review of the WHI-related literature.
Speroff L
Int J Fertil Womens Med; 2004; 49(6):252-67. PubMed ID: 15751264
[TBL] [Abstract][Full Text] [Related]
10. Failure of estrogen plus progestin therapy for prevention.
Fletcher SW; Colditz GA
JAMA; 2002 Jul; 288(3):366-8. PubMed ID: 12117403
[No Abstract] [Full Text] [Related]
11. Combined hormone therapy and breast cancer: a single-edged sword.
Gann PH; Morrow M
JAMA; 2003 Jun; 289(24):3304-6. PubMed ID: 12824214
[No Abstract] [Full Text] [Related]
12. [Hormone replacement therapy in menopause].
Breckwoldt M
Dtsch Med Wochenschr; 2003 Feb; 128(8):400. PubMed ID: 12594630
[No Abstract] [Full Text] [Related]
13. [Treatment with estrogen].
Ingelman-Sundberg A
Lakartidningen; 2002 Nov; 99(47):4777-8. PubMed ID: 12523062
[No Abstract] [Full Text] [Related]
14. Influence of postmenopausal hormone replacement therapy on an estrogen metabolite biomarker of risk for breast cancer.
Alvarez-Vasquez RB; Axelrod D; Frenkel K; Newman MC; Sepkovic DW; Bradlow HL; Zumoff B
Horm Metab Res; 2003 Jun; 35(6):358-61. PubMed ID: 12920658
[TBL] [Abstract][Full Text] [Related]
15. Discussing breast cancer and hormone replacement therapy with women.
Batur P; Thacker HL; Moore HC
Cleve Clin J Med; 2002 Nov; 69(11):838, 840, 843-4 passim. PubMed ID: 12430969
[TBL] [Abstract][Full Text] [Related]
16. Comparative effects of oral conjugated equine estrogens and micronized 17beta-estradiol on breast proliferation: a retrospective analysis.
Wood CE; Clarkson TB; Chen H; Veenstra TD; Xu X; Scott L; Cline JM
Menopause; 2008; 15(5):890-8. PubMed ID: 18520696
[TBL] [Abstract][Full Text] [Related]
17. Focus on cardiovascular health: hormone replacement therapy, estrogen replacement therapy, and selective estrogen receptor modulators.
Walsh BW
J Am Osteopath Assoc; 2003 Feb; 103(2 Suppl 2):S6-8. PubMed ID: 12625632
[No Abstract] [Full Text] [Related]
18. Estrogen-plus-progestin use and mammographic density in postmenopausal women: Women's Health Initiative randomized trial.
McTiernan A; Martin CF; Peck JD; Aragaki AK; Chlebowski RT; Pisano ED; Wang CY; Brunner RL; Johnson KC; Manson JE; Lewis CE; Kotchen JM; Hulka BS;
J Natl Cancer Inst; 2005 Sep; 97(18):1366-76. PubMed ID: 16174858
[TBL] [Abstract][Full Text] [Related]
19. The effect of medroxyprogesterone acetate on estrogen-dependent risks and benefits--an attempt to interpret the Women's Health Initiative results.
Kuhl H; Stevenson J
Gynecol Endocrinol; 2006 Jun; 22(6):303-17. PubMed ID: 16785155
[TBL] [Abstract][Full Text] [Related]
20. Combined estrogen and testosterone use and risk of breast cancer in postmenopausal women.
Tamimi RM; Hankinson SE; Chen WY; Rosner B; Colditz GA
Arch Intern Med; 2006 Jul; 166(14):1483-9. PubMed ID: 16864758
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
